Pharmacologic Prevention of Microvascular and Macrovascular Complications in Diabetes Mellitus: Implications of the Results of Recent Clinical Trials in Type 2 Diabetes

Author： Tandon Nikhil  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.12, Iss.1, 2012-02, pp. : 7-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of Intensive versus Conventional Glucose Control on Microvascular and Macrovascular Complications in Type 1 and 2 Diabetes Mellitus

By Mattila Taina K.   >  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2229-2245

Adis International

Access to resources Recommend Favorite

Economic Outcomes Associated with Microvascular Complications of Type 2 Diabetes Mellitus: Results from a US Claims Data Analysis

By Pelletier Elise M.  

PharmacoEconomics, Vol. 27, Iss. 6, 2009-06 ,pp. : 479-490

Adis International

Access to resources Recommend Favorite

The prevention of type 2 diabetes mellitus

By Davies Melanie J.  

Clinical Medicine, Vol. 3, Iss. 5, 2003-09 ,pp. : 470-474

Royal College Of Physicians

Access to resources Recommend Favorite

Preventing Macrovascular Disease in Patients with Type 2 Diabetes Mellitus

By Johansen O.E.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 4, 2003-01 ,pp. : 283-297

Adis International

Access to resources Recommend Favorite

Novel Cardiovascular Risk Factors and Macrovascular and Microvascular Complications of Diabetes

By  

Current Drug Targets, Vol. 4, Iss. 6, 2003-08 ,pp. : 477-486

Bentham Science Publishers

Access to resources Recommend Favorite